Studies by Wu et al. have demonstrated the possibility of the SEPT9 gene methylation assay as a reliable tool for opportunistic CRC detection with a sensitivity of 76.6% and a specificity of 95.9% [16]. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.